Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 000-17363 LIFEWAY FOODS, INC. (Exact name of registrant as specified in its charter) (State or other jurisd ...

Net sales of $44.6 million; up 17.8% year-over-year driven by volume growth of Lifeway Kefir 18th consecutive quarter of year-over-year growth MORTON GROVE, Ill., May 14, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the first quarter ended March 31, 2024. "Following our tremendous results in 2023, I am thrilled to report yet another record ...

Lifeway Foods, Inc. (LWAY) is likely to see top and bottom-line growth when it reports first-quarter 2024 earnings on May 14 before the opening bell. The Zacks Consensus Estimate for revenues is pegged at $43 million, which suggests growth of 13.5% from the prior-year quarter’s reported figure.The consensus mark for quarterly earnings has remained unchanged in the past 30 days at 24 cents per share. This indicates an increase of 300% from the year-ago quarter’s reported figure of 6 cents. LWAY has a trailin ...

Study protocol suggests consumption of probiotics in kefir positively alters the composition of the gut microbiome and may be linked to behavioral effects and improvements in sleep MORTON GROVE, Ill., May 8, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY), a leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, applauds the recent study protocol titled, "Randomised controlled trial of the effects of kefir on behaviour, sleep and the microbiome in children with ...

MORTON GROVE, Ill., May 7, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the first quarter ended March 31, 2024 on May 14, 2024 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details ...

Lifeway Foods (LWAY) ended the recent trading session at $21.49, demonstrating a +0.28% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.46%. Elsewhere, the Dow lost 0.98%, while the tech-heavy Nasdaq lost 0.64%.The the stock of dairy and cheese company has risen by 10.86% in the past month, leading the Consumer Staples sector's loss of 0.34% and the S&P 500's loss of 3.04%.Analysts and investors alike will be keeping a close eye on the perform ...

The most recent trading session ended with Lifeway Foods (LWAY) standing at $19.35, reflecting a +1.2% shift from the previouse trading day's closing. The stock outperformed the S&P 500, which registered a daily loss of 0.88%. On the other hand, the Dow registered a gain of 0.56%, and the technology-centric Nasdaq decreased by 2.05%.Shares of the dairy and cheese company have appreciated by 29.54% over the course of the past month, outperforming the Consumer Staples sector's loss of 3.55% and the S&P 500's ...

Lifeway Foods (LWAY) ended the recent trading session at $20.44, demonstrating a +1.09% swing from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.03%. Meanwhile, the Dow gained 0.41%, and the Nasdaq, a tech-heavy index, added 0.12%.Coming into today, shares of the dairy and cheese company had gained 90.57% in the past month. In that same time, the Consumer Staples sector lost 4.27%, while the S&P 500 lost 0.9%.Market participants will be closely following the financial r ...

Financial Data and Key Metrics Changes - Net sales for the year ended December 31, 2023, were $160.1 million, an increase of $18.6 million or 13.1% compared to the prior year, marking a record high for Lifeway [6][27] - Gross profit margin was 26.5% for the year, an increase of 760 basis points compared to the prior year, primarily due to higher volumes and favorable milk pricing [23] - Net income for the year was $11.4 million, reflecting EPS of $0.77 per basic and $0.75 per diluted common share, compared to net income of $0.9 million or $0.06 per share in the prior year [25] Business Line Data and Key Metrics Changes - The growth in net sales was primarily driven by higher volumes of Lifeway-branded drinkable kefir, with consistent volume growth throughout the year [22] - Farmers Cheese has seen increased demand, with strategic media activation to drive engagement and increased production to match demand [15] Market Data and Key Metrics Changes - The company has maintained strong relationships with key retail partners, leading to incremental placements of Lifeway products at major retailers such as Publix and Kroger [33] - The addressable market for kefir is expected to continue growing, driven by consumer preferences for healthy and high-quality food [29] Company Strategy and Development Direction - The company will continue to focus on its core products through strategic marketing and distribution opportunities to drive brand awareness and trial [14] - Lifeway is evaluating trends in the market and seeking incremental sales to improve product scope, particularly in the soft cheese category [30] Management's Comments on Operating Environment and Future Outlook - Despite macroeconomic challenges such as high interest rates and inflation, the company has not experienced a decline in demand, indicating strong consumer value perception [39] - Management expressed excitement about carrying momentum into 2024, aiming to deliver best-in-class probiotic and nutritious food [41] Other Important Information - Capital spending increased to $4.4 million, focusing on growth capital, cost reduction, and facility improvements [10] - The company produced over 30 million bottles of kefir in its Waukesha facility, marking a significant production milestone [11] Q&A Session Summary Question: How is Lifeway managing demand amidst economic challenges? - The company has not faced disruption or trade down on the demand side, demonstrating that its premium products offer exceptional value to consumers focused on quality [39] Question: What are the future growth prospects for Lifeway? - Management is optimistic about maintaining growth momentum and expanding profitability, with a focus on delivering high-quality products [41]

Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 LIFEWAY FOODS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer i ...